Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1990 2
1991 2
1992 10
1993 11
1994 5
1995 14
1996 11
1997 14
1998 11
1999 20
2000 21
2001 22
2002 23
2003 13
2004 41
2005 31
2006 35
2007 25
2008 32
2009 53
2010 72
2011 72
2012 126
2013 114
2014 122
2015 131
2016 163
2017 191
2018 170
2019 175
2020 188
2021 212
2022 214
2023 181
2024 230
2025 264
2026 197

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,029 results

Results by year

Filters applied: in the last 5 years. Clear all
Page 1
Gastroenteropancreatic neuroendocrine neoplasms: epidemiology, genetics, and treatment.
Tan B, Zhang B, Chen H. Tan B, et al. Front Endocrinol (Lausanne). 2024 Sep 30;15:1424839. doi: 10.3389/fendo.2024.1424839. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39411312 Free PMC article. Review.
The management of GEP NEN is diverse, but surgery remains the primary option for most cases. Peptide receptor radionuclide therapy (PRRT) is an effective treatment, and several clinical trials are exploring the potential of immunotherapy and targeted therapy, as well as co …
The management of GEP NEN is diverse, but surgery remains the primary option for most cases. Peptide receptor radionuclide therapy (PRRT
Structure and Function of Somatostatin and Its Receptors in Endocrinology.
Zhang B, Xue L, Wu ZB. Zhang B, et al. Endocr Rev. 2025 Jan 10;46(1):26-42. doi: 10.1210/endrev/bnae022. Endocr Rev. 2025. PMID: 39116368 Free article. Review.
Somatostatin analogs, such as octreotide, lanreotide, and pasireotide, which function as somatostatin receptor ligands (SRLs), are the main drugs used for the treatment of acromegaly. These ligands are also used as important molecules for radiation therapy and imagi …
Somatostatin analogs, such as octreotide, lanreotide, and pasireotide, which function as somatostatin receptor ligands (SRLs), …
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S. Ito T, et al. J Gastroenterol. 2021 Nov;56(11):1033-1044. doi: 10.1007/s00535-021-01827-7. Epub 2021 Sep 29. J Gastroenterol. 2021. PMID: 34586495 Free PMC article.
These revised guidelines also refer to the new concept of "neuroendocrine tumor" (NET) grade 3, which is based on the 2017 and 2019 WHO criteria; this includes health insurance coverage of somatostatin receptor scintigraphy for NEN, everolimus for lung and ga …
These revised guidelines also refer to the new concept of "neuroendocrine tumor" (NET) grade 3, which is based on the 2017 and …
Carcinoid Syndrome.
Menon G, Pandit S, Bhusal K. Menon G, et al. 2025 Oct 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. 2025 Oct 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 28846309 Free Books & Documents.
Carcinoid syndrome is a clinical condition caused by metastatic, well-differentiated neuroendocrine tumors, most commonly arising from the midgut with liver metastases, and is characterized by the secretion of biogenic amines, particularly serotonin, leading to symp …
Carcinoid syndrome is a clinical condition caused by metastatic, well-differentiated neuroendocrine tumors, most commonly aris …
Octreotide Scan.
Kapoor M, Kasi A. Kapoor M, et al. 2025 May 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. 2025 May 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 32644756 Free Books & Documents.
An octreotide scan, also known as somatostatin receptor scintigraphy (SRS), is valuable for detecting carcinoid tumors and various neuroendocrine tumors (NETs). ...The 2 types of imaging are based on these receptors. The first and most common is the …
An octreotide scan, also known as somatostatin receptor scintigraphy (SRS), is valuable for detecting carcinoid tumors and var …
Gastro-Enteric-Pancreatic Neuroendocrine Tumor Treatment: (177)Lu-DOTATATE.
Sanli Y, Denizmen D, Subramaniam RM. Sanli Y, et al. PET Clin. 2023 Apr;18(2):201-214. doi: 10.1016/j.cpet.2022.11.002. PET Clin. 2023. PMID: 36858745 Review.
177Lu-DOTA-TATE therapy is a highly effective therapy in metastatic, well-differentiated, somatostatin receptor-positive GEP-neuroendocrine tumors (NETs) with mostly tolerable adverse effects. ...Although we do not have sufficient data, 177Lu-DOTA-TATE
177Lu-DOTA-TATE therapy is a highly effective therapy in metastatic, well-differentiated, somatostatin receptor-positive GEP-neuro
Carcinoid tumors outside the abdomen.
Koehler K, Iams WT. Koehler K, et al. Cancer Med. 2023 Apr;12(7):7893-7903. doi: 10.1002/cam4.5564. Epub 2022 Dec 22. Cancer Med. 2023. PMID: 36560885 Free PMC article. Review.
Neuroendocrine tumors (NETs) are epithelial malignancies that can arise from multiple tissues. ...For patients with advanced disease, first-line systemic therapy is generally somatostatin analog monotherapy with octreotide or lanreotide. In patients wi
Neuroendocrine tumors (NETs) are epithelial malignancies that can arise from multiple tissues. ...For patients with advanced d
Neuroendocrine Tumors: Beta Labeled Radiopeptides.
Bodei L, Jayaprakasam VS, Ying Wong BZ, Aparici CM. Bodei L, et al. PET Clin. 2024 Jul;19(3S):e1-e11. doi: 10.1016/j.cpet.2024.06.003. Epub 2025 Apr 7. PET Clin. 2024. PMID: 40199623 Review.
Peptide receptor radionuclide therapy (PRRT) consists of administrating a radiolabeled octreotide derivative that targets somatostatin receptors present on the cell membrane of neuroendocrine tumor cells. Although PRRT was initially performed wi …
Peptide receptor radionuclide therapy (PRRT) consists of administrating a radiolabeled octreotide derivative that targets soma …
Lutetium-177 DOTATATE: A Practical Review.
Jia AY, Kashani R, Zaorsky NG, Spratt DE, Kiess AP, Michalski JM, Zoberi JE, Kim H, Baumann BC. Jia AY, et al. Pract Radiat Oncol. 2022 Jul-Aug;12(4):305-311. doi: 10.1016/j.prro.2022.02.002. Pract Radiat Oncol. 2022. PMID: 35717045 Review.
Neuroendocrine tumors (NETs) are a heterogeneous group of tumors that originate in endocrine tissues throughout the body. ...The phase III NETTER-1 trial found that [(177)Lu] Lu-DOTA-[Tyr(3)]-octreotate improved disease-free survival versus octreotide alone f
Neuroendocrine tumors (NETs) are a heterogeneous group of tumors that originate in endocrine tissues throughout the body. ...T
Gastroenteropancreatic Neuroendocrine Tumor Diagnosis: DOTATATE PET/CT.
Kandathil A, Subramaniam RM. Kandathil A, et al. PET Clin. 2023 Apr;18(2):189-200. doi: 10.1016/j.cpet.2022.11.001. Epub 2022 Dec 28. PET Clin. 2023. PMID: 36585339 Review.
Gastroenteropancreatic neuroendocrine tumors(NETs), which arise from the small intestine, rectum, colon, appendix, or pancreas, have variable malignant potential with clinical behavior determined by proliferative activity according to the Ki-67 index and tumor diffe …
Gastroenteropancreatic neuroendocrine tumors(NETs), which arise from the small intestine, rectum, colon, appendix, or pancreas …
1,029 results